Bioventus Inc.

From Bioventus's results release of 2. November 2026; its quarterly report has since been filed.

• Revenue

  Actual

  142,4M $

  +2,7 % y/y ↑
  -7,0 % q/q ↓

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  0,08 $

  +60 % y/y ↑
  -83 % q/q ↓

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  9,7M $

  -14 % y/y ↓
  -49 % q/q ↓

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.